As they act on different immune cells to IgG, IgE antibodies uniquely stimulate otherwise inactive immune cells in the ‘microenvironment’ surrounding the tumour to directly target the cancer cells. In ...

Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells and ...

IgE antibodies uniquely stimulate otherwise inactive immune cells in the 'microenvironment' surrounding the tumour to target the cancer cells directly. In the study, led by Dr Heather Bax at King ...